Aṇḍa - PDFSEARCH.IO - Document Search Engine

Aṇḍa
Results: 752

#	Item
611	[removed]Federal Register / Vol. 69, No[removed]Wednesday, August 4, [removed]Notices agency withdraws or suspends approval of the drug’s NDA or ANDA for reasons Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-08-04 08:41:31 Food and Drug Administration Piperazines Therapeutics United States Public Health Service Abbreviated New Drug Application Ofloxacin Emergency contraception Pharmaceutical sciences Pharmacology Medicine
612	erowe on DSK2VPTVN1PROD with Federal Register / Vol. 77, No[removed]Thursday, October 25, [removed]Notices ANDA and PAS fees will make up 24 percent of the $249,000,000, which is $59,760,000. Add to Reading List Source URL: www.gpo.gov Language: English - Date: 2012-10-25 00:48:06 Pharmaceuticals policy Medicine Health Food law Pharmacology Abbreviated New Drug Application Federal Food Drug and Cosmetic Act Drug Master File New Drug Application Pharmaceutical industry Pharmaceutical sciences Food and Drug Administration
613	User Fees Donal Parks, MBA, MPM Director User Fee Collections Staff Office of Management Add to Reading List Source URL: www.fda.gov Language: English Prescription Drug User Fee Act Fee Abbreviated New Drug Application Patent application User fee Credit card Anda Business Taxation in the United States Drug Master File Pharmaceutical industry
614	Microsoft Word - OGD RS QA ver16 final.doc Add to Reading List Source URL: www.fda.gov Language: English Clinical research Pharmaceutics Food and Drug Administration International Pharmaceutical Excipients Council Abbreviated New Drug Application Solvent Verification and validation Excipient Anda Pharmaceutical sciences Pharmaceutical industry Pharmacology
615	ANDA XX-XXX June 23, 2006 Sent by Facsimile and U.S. Mail Dear ANDA applicant: Add to Reading List Source URL: www.fda.gov Language: English Pharmaceuticals policy Chemistry BSE Sensex Ranbaxy Laboratories Generic drug Simvastatin Food and Drug Administration Abbreviated New Drug Application New Drug Application Pharmaceutical sciences Pharmacology Pharmaceutical industry
616	Guidance for Industry Changes to an Approved NDA or ANDA; Specifications – Use of Enforcement Discretion for Compendial Changes U.S. Department of Health and Human Services Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Medicine Pharmaceuticals policy Clinical research Therapeutics New Drug Application Regulatory requirement Center for Drug Evaluation and Research Title 21 CFR Part 11 Food and Drug Administration Pharmaceutical sciences Pharmaceutical industry
617	Euroopa sotsiaalpartnerite organisatsioonide esindavus: tekstiili- ja rõivasektor Kommenteeritud kokkuvõte Sissejuhatus Käesoleva aruande eesmärk on anda teavet, mida on vaja Add to Reading List Source URL: www.eurofound.europa.eu Language: Estonian - Date: 2014-02-07 06:25:29
618	Selle voldiku eesmärk on olla abiliseks raamatupidamise korraldamisel ning anda viiteid vastavatele seadustele, määrustele ja juhenditele, mida peavad ühendused jälgima oma igapäevatöös. Vastuseid leiate sagedami Add to Reading List Source URL: www.ngo.ee Language: Estonian - Date: 2011-05-23 16:37:46
619	Draft Guidance for Industry: ANDA Submissions – Amendments and Easily Correctable Deficiencies Under GDUFA Elizabeth Giaquinto, JD Office of Generic Drugs Add to Reading List Source URL: www.fda.gov Language: English Food and Drug Administration Pharmacology Therapeutics United States Public Health Service Constitutional amendment Medicinal chemistry Pharmaceutical sciences Clinical research Clinical pharmacology
620	Overview: Draft Guidance for Industry ANDA Submissions – Prior Approval Supplements Under GDUFA Martha Nguyen, JD Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Clinical research Pharmaceuticals policy Drug safety Therapeutics New Drug Application Generic drug Pharmaceutical sciences Pharmaceutical industry Food and Drug Administration

UPDATE